A groundbreaking shift in Canadian drug policy has taken place, as the authorities allow the availability of psilocybin fungi for therapeutic applications. Previously, these substances were heavily restricted, but a mounting body of studies suggests they could offer relief for mental health conditions like PTSD. This development represents a key st